Clinical Study

Acromegaly Clinical Registry

Posted Date: Feb 27, 2023

  • Investigator: Shailendra Patel
  • Specialties:
  • Type of Study: Observational/Survey

The MACRO registry will focus exclusively on patients with active acromegaly, defined operationally as an adult patient with a confirmed diagnosis of acromegaly being treated with medical therapy; or eligible to be treated with medical therapy, e.g., having an elevated IGF-1. The MACRO registry will be important for comparing different medical therapies with respect to disease- and treatment-associated symptoms, clinical characteristics of disease progression, treatment satisfaction, quality of life, work productivity, health resource utilization, breakthrough symptoms, injection-site reactions, treatment persistence/adherence, and treatment switching. Additionally, this registry will generate real-world evidence to aid payors in their decision-making process with respect to the introduction of any new oral medical therapies, under conditions of routine clinical care.


Must Have A Diagnosis Of Acromegaly


Growth Hormone

For More Information:

Shailendra Patel

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.